Gene Therapy Well-Tolerated in Late-Onset Pompe Disease
Interim safety data from the FORTIS study were presented at WORLDSympsoium.
Patient Dies in Phase 1b Mini-Dystrophin Gene Therapy Trial in DMD
The FDA has placed the investigational new drug application for the treatment on clinical hold.